Skip to main content
. 2021 Jan 7;7(2):e650. doi: 10.1097/TXD.0000000000001102

FIGURE 4.

FIGURE 4.

A single score that provides overall genetic risk, a polygenic risk score (PRS) can be achieved by combining of allograft rejection/loss associated-variants carried by an individual and in conjuncture with pharmacogenetics may be integrated into practice after clinical validation through prospective clinical trial supporting the clinical decision outlined. CMV, cytomegalovirus; CYP, Cytochrome P450.